Among his observations were that
GE traditionally has focused on taking their devices to the next level
technically. But now they need to be as concerned about bringing costs down and
making their products accessable in emerging markets. The coming years will be
about Quality, cost and access, Dineen said. He also said that GE needs to be
both clinically and economically relevant.
An example of a lower cost product
from GE is a new orthopaedic MR scanner, which only scans limbs, so patients
are not completely inserted in the scanner. It’s much more compact, less
intimidating to the patients, and the price is $500.000 – rather than $2
million for a full blown MR scanner.
John Dineen observed, that selling
to emerging markets means that GE needs to change their business model from
simply selling devices, to taking part in creating an entire local eco-system
of trained personal, maintenance, electrical charging etc.